More on BMY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+39.7% Growth)
- Ratings (3.2 Score)
- Holders
- Dividends (3.9% Yield)
- Event Driven Deals
- FDA
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/30/26 *Est.)
- M&A (9/30/19 *Est)
- M&A (12/31/20 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BMY Income Statement

Click line-items for a historical chart and %
Net Sales 4.92B
Cost of products sold 1.31B
Marketing, selling and administrative 1.14B
Advertising and product promotion
Research and development 1.14B
Provision for restructuring
Equity in net income of affiliates
Other (income)/expense -224M
Total Expenses 3.36B
Earnings Before Income Taxes 1.56B
Provision for income taxes 344M
Net Earnings 1.22B
Net Earnings Attributable to Noncontrolling Interest 13M
Net Earnings Attributable to Bristol-Myers Squibb Company 1.2B
Basic 0.72
Diluted 0.72
Dividends declared per common share 0.38

Entities mentioned with BMY

View All Entities